v3.25.2
Liquidity, Going Concern, and Restatement (Tables)
6 Months Ended
Jun. 30, 2025
Liquidity, Going Concern, and Restatement [Abstract]  
Schedule of Impact of the Restatement

The impact of the restatement on the balance sheets, statements of operations, and statements of cash flows as of and for the six months ended June 30, 2024 is presented below.

 

   June 30, 2024 
Unaudited Condensed
Consolidated Balance Sheets
  As
Reported
   Adjustments   As
Restated
 
Prepaid expense and other current asset  $100,810   $118,835   $219,645 
Current Assets   2,189,567    118,835    2,308,402 
Property and equipment, net   7,929,121    (7,400,000)   529,121 
Prepayment for asset acquisition   
-
    691,900    691,900 
Total Assets   14,633,699    (6,589,265)   8,044,434 
                
Accrued expenses and other current liabilities   3,961,050    (329,812)   3,631,238 
Due to related parties   326,298    (1,208)   325,090 
Current Liabilities   6,548,927    (302,016)   6,246,911 
Total Liabilities   6,805,409    (301,020)   6,504,389 
                
Additional paid-in capital   87,082,558    (9,053,103)   78,029,455 
Total stockholders’ equity   8,293,455    (6,507,253)   1,786,202 
Noncontrolling interest   (465,165)   219,008    (246,157)
Total Equity   7,828,290    (6,288,245)   1,540,045 
Total Liabilities and Equity  $14,633,699   $(6,589,265)  $8,044,434 

 

   Three Months Ended June 30, 2024 
Unaudited Condensed
Consolidated Statements of Operations
  As
Reported
   Adjustments   As
Restated
 
Selling, general and administrative expenses  $640,451   $13,332   $653,783 
Stock based compensation   412,741    (129,866)   282,875 
Interest expenses   (260,032)   52,953    (207,079)
Net loss attributable to noncontrolling interests   (206,044)   100,968    (105,076)
Net loss   (1,272,689)   225,277    (1,047,412)
Basic and diluted net loss per common share  $(0.09)  $0.01   $(0.08)
   Six Months Ended June 30, 2024 
Unaudited Condensed
Consolidated Statements of Operations
  As
Reported
   Adjustments   As
Restated
 
Selling, general and administrative expenses  $1,471,708   $(79,439)  $1,392,269 
Stock based compensation   2,957,736    (643,230)   2,314,506 
Interest expenses   (944,715)   555,960    (388,755)
Net loss attributable to noncontrolling interests   (308,087)   109,543    (198,544)
Net loss   (5,253,708)   1,278,629    (3,975,079)
Basic and diluted net loss per common share  $(0.47)  $0.11   $(0.36)

 

   Six Months Ended June 30, 2024 
Unaudited Condensed
Consolidated Statements of Cash Flows
  As
Reported
   Adjustments   As
Restated
 
Net loss  $(5,253,708)  $1,278,629   $(3,975,079)
Stock-based compensation   2,957,736    (643,230)   2,314,506 
Other non-cash income and expenses   915,546    (553,972)   361,574 
Prepaid expenses and other deposits   7,245    72,914    80,159 
Accrued expenses and other current liabilities   264,670    (182,772)   81,898 
Due from related parties*   (518,615)   501,614    (17,001)
Due to related parties   153,166    (153,166)   
-
 
Net cash used in operating activities   (1,487,258)   320,017    (1,167,241)
Loan to related parties*   
-
    (501,614)   (501,614)
Net cash used in investing activities*   
-
    (501,614)   (501,614)
Due to related parties*   
-
    151,597    151,597 
Proceeds from short-term borrowings*   
-
    30,000    30,000 
Net cash provided by financing activities   1,544,706    181,597    1,726,303 
                
Issuance of common stock for conversion of debt  $811,174   $(241,492)  $569,682 

  

* Previously reported amount was reclassified to financing activities based on current year’s presentation.